Malondialdehyde Monoclonal Antibody

Overview
The Malondialdehyde (MDA) Monoclonal Antibody (Clone 11E3) is a highly specific mouse IgG1 antibody designed for the detection of MDA, a well-established biomarker of oxidative stress and lipid peroxidation. This antibody is validated for multiple applications including Western Blot, ELISA, Immunohistochemistry, and Immunofluorescence, making it an essential tool for research in cancer, metabolic disorders, neurodegenerative diseases, and aging.

Background
Malondialdehyde (MDA) is a stable end-product of lipid peroxidation and a widely used biomarker for oxidative stress. It readily forms adducts with proteins and nucleic acids, contributing to cellular damage. Elevated MDA levels are associated with numerous pathological conditions, including breast cancer, lung cancer, diabetes, Alzheimer’s disease, and cardiovascular disorders. Detection of MDA is crucial for assessing oxidative damage in experimental and clinical research.

Research Applications
Ideal for:

• Oxidative stress and lipid peroxidation studies

• Cancer biomarker research (breast, lung, etc.)

• Neurodegenerative disease models (Alzheimer’s, Parkinson’s)

• Metabolic disorder analysis (diabetes, obesity)

• Cardiovascular and aging research

• Toxicology and drug development studies

Note: For research use only. Not for diagnostic or therapeutic use.